GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Garden Biopharmaceutical Co Ltd (SZSE:300401) » Definitions » EV-to-FCF

Zhejiang Garden Biopharmaceutical Co (SZSE:300401) EV-to-FCF : -48.47 (As of Jun. 04, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Zhejiang Garden Biopharmaceutical Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Zhejiang Garden Biopharmaceutical Co's Enterprise Value is ¥6,427 Mil. Zhejiang Garden Biopharmaceutical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-133 Mil. Therefore, Zhejiang Garden Biopharmaceutical Co's EV-to-FCF for today is -48.47.

The historical rank and industry rank for Zhejiang Garden Biopharmaceutical Co's EV-to-FCF or its related term are showing as below:

SZSE:300401' s EV-to-FCF Range Over the Past 10 Years
Min: -2964.24   Med: -36.66   Max: 958.37
Current: -49.74

During the past 13 years, the highest EV-to-FCF of Zhejiang Garden Biopharmaceutical Co was 958.37. The lowest was -2964.24. And the median was -36.66.

SZSE:300401's EV-to-FCF is ranked worse than
100% of 532 companies
in the Drug Manufacturers industry
Industry Median: 22.76 vs SZSE:300401: -49.74

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-04), Zhejiang Garden Biopharmaceutical Co's stock price is ¥11.47. Zhejiang Garden Biopharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.380. Therefore, Zhejiang Garden Biopharmaceutical Co's PE Ratio for today is 30.18.


Zhejiang Garden Biopharmaceutical Co EV-to-FCF Historical Data

The historical data trend for Zhejiang Garden Biopharmaceutical Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Garden Biopharmaceutical Co EV-to-FCF Chart

Zhejiang Garden Biopharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -70.55 -45.86 -38.54 -2,770.98 -79.04

Zhejiang Garden Biopharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -157.80 -76.87 -47.35 -79.04 -41.12

Competitive Comparison of Zhejiang Garden Biopharmaceutical Co's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Garden Biopharmaceutical Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Garden Biopharmaceutical Co's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Garden Biopharmaceutical Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Zhejiang Garden Biopharmaceutical Co's EV-to-FCF falls into.



Zhejiang Garden Biopharmaceutical Co EV-to-FCF Calculation

Zhejiang Garden Biopharmaceutical Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=6427.160/-132.595
=-48.47

Zhejiang Garden Biopharmaceutical Co's current Enterprise Value is ¥6,427 Mil.
Zhejiang Garden Biopharmaceutical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-133 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhejiang Garden Biopharmaceutical Co  (SZSE:300401) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Zhejiang Garden Biopharmaceutical Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=11.47/0.380
=30.18

Zhejiang Garden Biopharmaceutical Co's share price for today is ¥11.47.
Zhejiang Garden Biopharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.380.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Zhejiang Garden Biopharmaceutical Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Zhejiang Garden Biopharmaceutical Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Garden Biopharmaceutical Co (SZSE:300401) Business Description

Traded in Other Exchanges
N/A
Address
No. 166, Street 20, Economic & Technological Development Zone, Zhejiang, Hangzhou, CHN, 310018
Zhejiang Garden Biopharmaceutical Co Ltd is a China-based company. Along with its subsidiaries, the firm is engaged in the pharmaceutical manufacturing. Its business activities include research, production, and sale of vitamin D3, cholesterol, and lanolin products. Its products include lanolin alcohol pharma, lanolin alcohol cosmetic, cholesterol BP, vitamin D3 oil feed grade, vitamin D3 500 feed grade CWS, lanolin alcohol EP 200, among others.
Executives
Shao Xu Jun Director
Liu Xiao Ping Executives
Shao Qin Xiang Director
Shao Jun Fang Director
Liu Jian Gang Directors, executives
Qian Guo Ping Executives
Zhu Jian Xing Supervisors
Yu Quan Heng Directors, executives, directors
Ma Huan Zheng Directors, executives
Li Hui Ying Supervisors
Ma Wen De Director
Chen Yi Executives
Gu Yi Kang Independent director

Zhejiang Garden Biopharmaceutical Co (SZSE:300401) Headlines

No Headlines